adenosine monophosphate has been researched along with MEA 2a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, RZ; Coupal, E; Fulmer, ML; Mao, R; Margraf, RL; Miller, CE | 1 |
1 other study(ies) available for adenosine monophosphate and MEA 2a
| Article | Year |
|---|---|
Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG/AMP variant classification guidelines and impact on the MEN2 RET database.
Topics: Adenosine Monophosphate; Carcinoma, Medullary; Humans; Multiple Endocrine Neoplasia Type 2a; Proto-Oncogene Proteins c-ret; Syndrome; Thyroid Neoplasms | 2022 |